Respiratory Syncytial Virus: Update on Infection, Treatment, and Prevention (Q45737133)

15 December 2017

Respiratory Syncytial Virus: Update on Infection, Treatment, and Prevention (English)

1 reference

15 December 2017

Leonard R. Krilov

1

1 reference

PubMed ID

11384554

15 December 2017

language of work or name

1 reference

1 June 2001

1 reference

Current infectious disease reports

15 December 2017

1 reference

15 December 2017

3

1 reference

15 December 2017

3

1 reference

15 December 2017

242-246

1 reference

From the National Institute of Allergy and Infectious Diseases and the World Health Organization. Respiratory syncytial and parainfluenza viruses

15 December 2017

1 reference

https://api.crossref.org/works/10.1007%2FS11908-001-0026-3

Neonatal respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-001-0026-3

Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-001-0026-3

Prospective follow-up and pulmonary functions from a placebo-controlled randomized trial of ribavirin therapy in respiratory syncytial virus bronchiolitis. Ribavirin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-001-0026-3

Prospects for a respiratory syncytial virus vaccine

21 January 2018

1 reference

12 December 2020

The Efficacy of Nebulized Metaproterenol in Wheezing Infants and Young Children

1 reference

12 December 2020

Evaluation of a rapid diagnostic test for respiratory syncytial virus (RSV): potential for bedside diagnosis.

1 reference

12 December 2020

A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment of acute bronchiolitis

1 reference

12 December 2020

Reduced long-term respiratory morbidity after treatment of respiratory syncytial virus bronchiolitis with ribavirin in previously healthy infants: a preliminary report

1 reference

12 December 2020

Epidemiologic evidence of increased airway reactivity in children with a history of bronchiolitis

1 reference

12 December 2020

Modes of transmission of respiratory syncytial virus

1 reference

12 December 2020

Pulmonary function abnormalities in symptom-free children after bronchiolitis

1 reference

12 December 2020

Cost-effectiveness of respiratory syncytial virus prophylaxis among preterm infants

1 reference

12 December 2020

Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group

1 reference

12 December 2020

Impact of palivizumab on expected costs of respiratory syncytial virus infection in preterm infants: potential for savings

1 reference

12 December 2020

Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group

1 reference

12 December 2020

Influenza and respiratory syncytial virus. Update on infection, management, and prevention

1 reference

12 December 2020

Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group

1 reference

12 December 2020

Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada

1 reference

12 December 2020

Efficacy of Directigen RSV testing in patient management following admission from a paediatric emergency department

1 reference

12 December 2020

Nosocomial Respiratory Syncytial Virus Infections

1 reference

12 December 2020

Bronchiolitis-associated hospitalizations among US children, 1980-1996.

1 reference

12 December 2020

Outpatient assessment of infants with bronchiolitis

1 reference

12 December 2020

Study of 8-year-old children with a history of respiratory syncytial virus bronchiolitis in infancy

1 reference

12 December 2020

Efficacy of albuterol in the management of bronchiolitis

1 reference

12 December 2020

Follow-up of children with respiratory syncytial virus bronchiolitis in 1986 and 1987: potential effect of ribavirin on long term pulmonary function. The Bronchiolitis Study Group

1 reference

12 December 2020

Prevention of respiratory syncytial virus infection in high risk infants: consensus opinion on the role of immunoprophylaxis with respiratory syncytial virus hyperimmune globulin

1 reference

12 December 2020

High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection

1 reference

12 December 2020

Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy

1 reference

12 December 2020

Maternal antibody and respiratory syncytial virus infection in infancy

1 reference

12 December 2020

Effect of salbutamol on oxygen saturation in bronchiolitis

1 reference

12 December 2020

Risk of secondary bacterial infection in infants hospitalized with respiratory syncytial viral infection

1 reference

12 December 2020

Long term follow-up of children hospitalized with respiratory syncytial virus lower respiratory tract infection and randomly treated with ribavirin or placebo

1 reference

12 December 2020

Respiratory syncytial virus infection in adult BMT recipients: effective therapy with short duration nebulised ribavirin

1 reference

12 December 2020

Severity of respiratory syncytial virus infection is related to virus strain

1 reference

12 December 2020

10.1007/S11908-001-0026-3

Identifiers

DOI

1 reference

15 December 2017

1 reference

PubMed ID

11384554